Skip to content

Home-based dyadic mindfulness yoga programme for patients with Parkinson's disease and their caregivers

A home-based dyadic mindfulness yoga programme for patients with moderate-advanced Parkinson’s disease and their family caregivers: a feasibility trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200065417
Enrollment
Unknown
Registered
2022-11-04
Start date
2022-11-07
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's disease

Interventions

2:Usual control

Sponsors

The University of Hong Kong
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 80 Years

Inclusion criteria

Inclusion criteria: We will recruit Chinese patients with idiopathic moderate-advanced PD (as indicated by the Hoehn and Yahr Scale stages III-IV: those with unilateral/bilateral symptoms, with/without postural instability who are able to walk or stand unassisted) and their family caregivers. For the patient, they need to be: 1. Aged between 50-80 years; 2. Experienced at least mild depressive symptoms–as indicated by a Patient Health Questionnaire-9 (PHQ-9) score >= 5 (15)–to ensure they are exposed to the core problem addressed by this study. As for the caregivers, they need to be self-identified as the primary co-residing caregivers of the patient counterparts for at least three months. Both of them need to be able to communicate in Cantonese. They will only be eligible if both the patient and caregiver in a dyad provide written consent to participate.

Exclusion criteria

Exclusion criteria: Exclusion criteria are: 1. Have been engaged in regular systematic mind-body practices such as Tai Chi, qigong, yoga or other forms of mindfulness training (> 2 times per week) in the past 3 months; 2. Have pre-existing acute psychotic disease; 3. Are currently participating in any other behavioural or pharmacological trial; 4. Have significant cognitive impairment as indicated by the Abbreviated Mental Test score <= 6; 5. Have other contraindication(s) that may limit their full participation (e.g., severe hearing or vision impairment, etc.).

Design outcomes

Primary

MeasureTime frame
Depression (dyadic outcome);

Secondary

MeasureTime frame
Anxiety (dyadic outcome);Social support (dyadic outcome);Mindfulness (dyadic outcome);HRQOL (dyadic outcome);PD-related motor and non-motor symptoms (care-recipient outcome);Caregiving burden (caregiver outcome);

Countries

China

Contacts

Public ContactJojo Yan Yan Kwok

The University of Hong Kong

jojoyyk@hku.hk+852 39176644

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026